LAS VEGAS--(BUSINESS WIRE)--CardioVascular BioTherapeutics, Inc. (OTCBB:CVBT) has today announced that it is seeking to list its shares on the London Stock Exchange’s Alternative Investment Market, or “AIM.”
LAS VEGAS--(BUSINESS WIRE)--CardioVascular BioTherapeutics, Inc. (OTCBB:CVBT) has today announced that it is seeking to list its shares on the London Stock Exchange’s Alternative Investment Market, or “AIM.”
